Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferro Desideri

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal Francais D'Ophtalmologie|July 22, 2023
Decompression retinopathyL Ferro Desideri, R Anguita
Journal Francais D'Ophtalmologie|May 2, 2024
Mirror hypopyon in a patient with silicone oil tamponade and an active corneal ulcerL Ferro Desideri, R Anguita
Drugs of Today (Barcelona, Spain : 1998)|May 15, 2020
An update on conbercept to treat wet age-related macular degenerationL Ferro Desideri, C E Traverso, M Nicolò
Drugs of Today (Barcelona, Spain : 1998)|August 18, 2021
Razumab -- the role of biosimilars for the treatment of retinal diseasesL Ferro Desideri, C A Cutolo, C E Traverso, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 29, 2019
Omidenepag isopropyl for the treatment of glaucoma and ocular hypertensionL Ferro Desideri, C A Cutolo, F Barra, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 7, 2020
An update on ripasudil for the treatment of glaucoma and ocular hypertensionV Testa, L Ferro Desideri, P Della Giustina, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2021
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overviewP Viola, V Testa, L Ferro Desideri, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal Francais D'Ophtalmologie|July 22, 2023
Decompression retinopathyL Ferro Desideri, R Anguita
Journal Francais D'Ophtalmologie|May 2, 2024
Mirror hypopyon in a patient with silicone oil tamponade and an active corneal ulcerL Ferro Desideri, R Anguita
Drugs of Today (Barcelona, Spain : 1998)|May 15, 2020
An update on conbercept to treat wet age-related macular degenerationL Ferro Desideri, C E Traverso, M Nicolò
Drugs of Today (Barcelona, Spain : 1998)|August 18, 2021
Razumab -- the role of biosimilars for the treatment of retinal diseasesL Ferro Desideri, C A Cutolo, C E Traverso, et al.
Drugs of Today (Barcelona, Spain : 1998)|June 29, 2019
Omidenepag isopropyl for the treatment of glaucoma and ocular hypertensionL Ferro Desideri, C A Cutolo, F Barra, et al.
Drugs of Today (Barcelona, Spain : 1998)|October 7, 2020
An update on ripasudil for the treatment of glaucoma and ocular hypertensionV Testa, L Ferro Desideri, P Della Giustina, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2021
Aflibercept, ranibizumab and bevacizumab upcoming biosimilars: a general overviewP Viola, V Testa, L Ferro Desideri, et al.
Pageof 1